Ziprasidone capsules – 20 mg, 40 mg, 60 mg and 80 mg
From 1 November 2015, PHARMAC is making a change to the funded brand of ziprasidone tablets.
What is changing?
The funded brand of ziprasidone will change from Zeldox to a new brand, Zusdone.
When will the change occur?
From 1 November 2015 the Zusdone brand of ziprasidone will be fully subsidised and listed on the Pharmaceutical Schedule.
From 1 January 2016 a part payment may be required for the Zeldox brand. To avoid this part payment, your pharmacist will dispense you Zusdone brand of ziprasidone.
From 1 April 2016 only the Zusdone brand of ziprasidone will be funded when you pick up your prescription. The Zeldox brand may or may not be available after this date (at the discretion of the supplier, Pfizer) and will not be funded.
Doctors, nurses and pharmacists have been kept informed about these changes and are the best people to discuss these changes with you.
Will the medicine work in the same way?
Your medicine itself is not changing, only the brand. The newly funded tablets contain the same amount of the active ingredient – ziprasidone. This means that the effect you experience when taking the Zusdone brand of ziprasidone should be the same as the brand you are currently taking.
You shouldn’t notice any difference in how you feel after taking the Zusdone brand of ziprasidone. If you do notice any major changes or side effects, please talk with your doctor or nurse about it.
Will there be any extra costs for me to pay?
Other than the usual patient co-payment, there will be no extra cost for you to pay.
Will the tablets or pack look different?
Because they are made by a different supplier, the Zusdone brand of ziprasidone capsules and pack look a little different to your previous medication. The capsules will still come in a blister pack.
Why has this change happened?
Significant savings are associated with the move to the Zusdone brand of ziprasidone capsules. This means that more money can be freed up to fund other medicines to treat other people in our communities. Rest assured, this medication has been approved by Medsafe, New Zealand’s medicines regulator.
Where can I get more information?
If you have any questions about the change please contact us at email@example.com.
Your health professional will also help you during the changeover period.
Last updated: 18 August 2016